Barriers to Attainment of Glycemic Outcomes in Human Immunodeficiency Virus and Type 2 Diabetes
- Research team: Principal investigator Veronica Brady, PhD, FNP-BC
- Funding sponsor: Texas Developmental Center for AIDS Research (TX D-CFAR)
- Overview: The team retrospectively reviews charts of patients at Harris Health System’s Thomas Street at Quentin Mease Health Center to assess the prevalence of Type 2 diabetes among minorities with HIV and discern variations by age, race, and sex assigned at birth. Her team will then compare A1c and blood glucose levels among people with Type 2 diabetes only to those with Type 2 diabetes and HIV.
- Budget: $50,000
Impact of Type 2 Diabetes on Aging Among People with HIV
- Research team: Principal investigator Veronica Brady, PhD, FNP-BC. Mentors Cizik School of Nursing Dean Diane Santa Maria, DrPH, MSN, ACRN, PHNA-BC, FAAN, and Professor Nahid Rainon, MD, DrPH, AGSF, of McGovern Medical School at UTHealth Houston. Co-investigators McGovern Medical School Professor Robin Hardwicke, PhD, RN, and Nadia Salas, DNP, GNP, of UT Physicians.
- Funding sponsor: National Institute on Aging via the HIV and Aging Research Consortium and the University of Washington
- Overview: This study incorporates bone mineral bone density (BMD) testing and trabecular bone scores (TBS) to assess aging bone health among patients with HIV, with both HIV and Type 2 diabetes, and without either disease.
- Project period: September 2024 to September 2025
